undamentalytics Newsletter
Sign in

Endovia Health Sciences, Inc. income statement

In fiscal 2025, Endovia Health Sciences, Inc. reported revenue of $73,066, down 90.9% on the year before, operating income of −$14.2m (a -19415.6% margin) and net income of −$25.2m, or −$11.97 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0001111102111819100
Cost of revenue——————0102712134——
Gross profit00000101−00466−000
Selling, general and administrative—————0000———————
Selling and marketing—————————0132000
General and administrative000—————————————
Operating income−0−00−00−0−00−4−18−29−21−15−10−14−14
Interest expense−0−00000000—002432
Net interest income————————−1−2−0—−2−4−3−2
Income tax—————00000000000
Net income−0−0−0−00−0−00−5−29−29−22−21−24−25−17
Diluted EPS−$2.93$0.00$0.00$0.00$0.00$0.00−$2.93$2.93−$11.73−$310.80−$299.07——−$17.68−$11.97—
Diluted shares (average)—————————63m———1m2m—
EBITDA——0000−00−4−18−29−20−15−9−14−14

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: EDVA vs YHCEDVA vs IBGEDVA vs EPSM

More: Beverages stocks compared, Consumer Staples sector, rankings of US companies

Figures from Endovia Health Sciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Endovia Health Sciences, Inc.